pembrolizumab
merck
['biomarker', 'pembro', 'keynote 604']
another example of how we don't have robust biomarker for io . keynote 604 analysis. tmb has no correlation with pembro response. infact lower tmb was associated with better response with pembrolizumab . is there any explanation for this ? 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists